top of page
Efficacy and Safety of Radiofrequency Ablation Versus Observation for Nonfunctioning Benign Thyroid Nodules: A Randomized Controlled International Collaborative Trial
Efficacy and Safety of Radiofrequency Ablation Versus Observation for Nonfunctioning Benign Thyroid Nodules: A Randomized Controlled International Collaborative Trial
Citation
Deandrea, M., Sung, J. Y., Limone, P., Mormile, A., Garino, F., Ragazzoni, F., … Baek, J. H. (2015). Efficacy and Safety of Radiofrequency Ablation Versus Observation for Nonfunctioning Benign Thyroid Nodules: A Randomized Controlled International Collaborative Trial. Thyroid, 25(8), 890–896. doi:10.1089/thy.2015.0133
URL
Abstract
Background:
Percutaneous radiofrequency thermal ablation (RFA) has been reported as an effective tool for the management of benign thyroid nodules (BTN). However, large, randomized controlled trials (RCTs) are lacking.
Objective:
The aims of this study were to assess the volume reduction of BTN after a single RFA performed using the moving-shot technique and to compare the volume reduction obtained in patients treated in two centers with different experience of the moving-shot technique.
Method:
This study was an international prospective RCT. It was carried out at the Mauriziano Hospital (Turin, Italy) and the Asan Medical Center (Seoul, Korea). Eighty patients harboring solid, compressive, nonfunctioning BTN (volume 10–20 mL) were enrolled. Twenty patients in each country were treated by RFA using a 18-Gauge internally cooled electrode (group A); 20 nontreated patients in each country were followed as controls (group B).
Conclusion
At six months, BTN volume significantly decreased in group A (15.1 – 3.1 mL vs. 4.2 – 2.7 mL; p < 0.0001), whereas it remained unchanged in group B (14.4 – 3.3 mL vs. 15.2 – 3.5 mL). The baseline volume was larger in the Italian series (16.4 – 2.5 mL vs. 13.9 – 3.3 mL, p = 0.009). However, at six months, there was no significant difference between the Korean group and the Italian group (3.7 – 2.9 mL vs. 5.5 – 2.2 mL). Both cosmetic and compressive symptoms significantly improved (3.6 – 0.5 vs. 1.7 – 0.4 and 3.6 – 1.9 vs. 0.4 – 0.7, respectively; p
Key Words
thyroid nodule, RFA, BTN, Percutaneous radiofrequency thermal ablation, benign thyroid nodules
Contact Us
Address
2320 N. Third Street
Phoenix, AZ 85004
Contact
tel: 602-889-2923
fax: 602-889-2925 / 602-889-2926
Opening Hours
Mon - Thurs
7:30 am – 4:30 pm
Friday
7:30 am – 4:00 pm
Closed M-F
12:00 - 1:00 pm Lunch
bottom of page